Medullary thyroid cancer outcomes in patients with undetectable versus normalized postoperative calcitonin levels
- PMID: 33899100
- DOI: 10.1093/bjs/znab106
Medullary thyroid cancer outcomes in patients with undetectable versus normalized postoperative calcitonin levels
Abstract
Background: Calcitonin (Ct) is a sensitive diagnostic biomarker and one of the most important prognostic factors in medullary thyroid cancer (MTC). This study aimed to evaluate progression-free survival and recurrence rates of MTC associated with undetectable compared with normalized serum Ct levels after surgery.
Methods: This retrospective observational study included patients operated for MTC at the Digestive and Endocrine Surgery Department of Lyon Sud Hospital Centre between 2000 and 2019. Clinical and pathological factors were correlated with postoperative Ct concentrations. Undetectable and normalized Ct concentrations were defined as below 2 pg/ml and 2-10 pg/ml respectively.
Results: Overall, 176 patients were treated for MTC, and 127 were considered biochemically cured after surgery. Of these, 24 and 103 had normalized and undetectable Ct concentrations respectively. Patients with Ct level normalization had a 25 per cent risk of disease recurrence, compared with 3 per cent in patients with undetectable Ct levels after surgery. The presence of metastasis in two or more compartments was predictive of failure to achieve undetectable Ct concentrations after surgery and an increased risk of recurrence.
Conclusion: Among patients with biochemically cured MTC, those with undetectable or normalized Ct concentrations after surgery had different risks of recurrence. Simply assessing postoperative Ct normalization can be falsely reassuring, and long-term follow-up is needed.
Lay summary: Calcitonin (Ct) is a sensitive diagnostic biomarker and one of the most important prognostic factors for medullary thyroid cancer outcomes; however, the significance of postoperative Ct levels remains controversial. This study evaluated the differences between normal and undetectable postoperative Ct levels in patients who had undergone surgical treatment for medullary thyroid cancer. Patients who experienced postoperative Ct level normalization had a higher risk of disease recurrence than those with undetectable Ct levels after surgery.
Plain language summary
Calcitonin (Ct) is a sensitive diagnostic biomarker and one of the most important prognostic factors for medullary thyroid cancer outcomes; however, the significance of postoperative Ct levels remains controversial. This study evaluated the differences between normal and undetectable postoperative Ct levels in patients who had undergone surgical treatment for medullary thyroid cancer. Patients who experienced postoperative Ct level normalization had a higher risk of disease recurrence than those with undetectable Ct levels after surgery.
© The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.Front Endocrinol (Lausanne). 2021 Nov 5;12:747704. doi: 10.3389/fendo.2021.747704. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34803914 Free PMC article.
-
Serum calcitonin nadirs to undetectable levels within 1 month of curative surgery in medullary thyroid cancer.Arch Endocrinol Metab. 2019 Mar-Apr;63(2):137-141. doi: 10.20945/2359-3997000000112. Epub 2019 Mar 21. Arch Endocrinol Metab. 2019. PMID: 30916162 Free PMC article.
-
Long-Term Follow-up in Medullary Thyroid Carcinoma.Recent Results Cancer Res. 2015;204:207-25. doi: 10.1007/978-3-319-22542-5_10. Recent Results Cancer Res. 2015. PMID: 26494391 Review.
-
Survival in medullary thyroid carcinoma patients who fail to achieve a biochemical cure: implications of postoperative 1-month calcitonin levels and targeted therapy.World J Surg Oncol. 2024 Sep 12;22(1):249. doi: 10.1186/s12957-024-03527-x. World J Surg Oncol. 2024. PMID: 39267073 Free PMC article.
-
Mild to moderate increase of serum calcitonin levels only in presence of large medullary thyroid cancer deposits.Rev Esp Med Nucl Imagen Mol. 2015 Nov-Dec;34(6):378-82. doi: 10.1016/j.remn.2015.05.007. Epub 2015 Sep 26. Rev Esp Med Nucl Imagen Mol. 2015. PMID: 26420439 Review. English, Spanish.
Cited by
-
Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma.Front Endocrinol (Lausanne). 2022 Nov 23;13:1025629. doi: 10.3389/fendo.2022.1025629. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36506082 Free PMC article.
-
Epidemiology, Clinical Presentation, and Diagnosis of Medullary Thyroid Carcinoma.Recent Results Cancer Res. 2025;223:93-127. doi: 10.1007/978-3-031-80396-3_4. Recent Results Cancer Res. 2025. PMID: 40102255 Review.
-
Management of medullary thyroid cancer based on variation of carcinoembryonic antigen and calcitonin.Front Endocrinol (Lausanne). 2024 Oct 10;15:1418657. doi: 10.3389/fendo.2024.1418657. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39449744 Free PMC article. Review.
-
Thyroid Nodules: Emerging Trends in Detection and Visualization based on Citespace.Endocr Metab Immune Disord Drug Targets. 2024;24(1):130-141. doi: 10.2174/1871530323666230822143549. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 37608676 Free PMC article.
-
Synchronous occurrence of papillary thyroid carcinoma and medullary thyroid carcinoma in the setting of Hashimoto's thyroiditis: a case report with literature review.Gland Surg. 2025 Jul 31;14(7):1406-1414. doi: 10.21037/gs-2025-141. Epub 2025 Jul 28. Gland Surg. 2025. PMID: 40771377 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical